Santa Maria Biotherapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Santa Maria Biotherapeutics, Inc. - overview
Established
2012
Location
Brisbane, CA-California, US
Primary Industry
Healthcare Specialists
About
Founded in 2012 and based in California, US, Santa Maria Biotherapeutics, Inc. engages in the development of therapies for the mitigation of cachexia in the treatment of ovarian cancer.
Current Investors
Domain Associates, Kleiner Perkins, DAG Ventures
Primary Industry
Healthcare Specialists
Sub Industries
Oncology/Cancer Treatment
Company Stage
Series B
Total Amount Raised
Subscriber access only
Santa Maria Biotherapeutics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B | Completed | Santa Maria Biotherapeutics, Inc. | - |
Displaying 1 - 1 of 1
Santa Maria Biotherapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.